【レポートの概要（一部）】
1. Executive Summary
1.1 Overview of Findings
1.2 Structure of the Report
1.3 Global Next-Generation Cancer Diagnostics Market Segmentation
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Next-Generation Cancer Diagnostics
2.1 What Is Cancer?
2.2 Cancer Diagnostics: An Overview
2.2.1 Screening
2.2.2 Diagnosis
2.2.3 Staging
2.3 Cancer Diagnosis Methods
2.3.1 Physical Examination
2.3.2 Imaging Techniques
2.3.2.1 Ultrasound
2.3.2.2 Computed Tomography (CT)
2.3.2.3 Magnetic Resonance Imaging (MRI)
2.3.2.4 Positron Emission Tomography (PET)
2.3.3 Histopathological and Cytological Techniques
2.3.4 Immunohistochemistry (IHC) Analysis
2.3.5 Circulating Tumour Cell (CTC) Analysis
2.3.6 Molecular Diagnostics and IVD
2.3.6.1 Polymerase Chain Reaction (PCR)
2.3.6.2 Multiplex PCR
2.3.6.3 Real-Time PCR (RT-PCR or qPCR)
2.3.6.4 Digital PCR (dPCR)
2.3.6.5 In Situ Hybridisation (ISH)
2.3.6.6 Microarray
2.3.6.7 Next-Generation Sequencing (NGS)
2.4 Tests for Inherited and Acquired Genetic Mutations
2.5 Companion Diagnostics (CDx)
2.6 Laboratory Developed Test (LDT)
2.7 Precision Medicine
2.8 Government Regulations
2.8.1 The US Approval and Regulation System
2.8.2 The EU Approval and Regulation System
2.9 Market Definition
3. Next-Generation Cancer Diagnostics: World Market 2015-2025
3.1 The Global Next-Generation Cancer Diagnostics Market: Overview
3.2 The Global Next-Generation Cancer Diagnostics Market Forecast 2015-2025
3.3 How Will Segmental Market Shares Change to 2025?
3.4 Biomarkers and Molecular Diagnostics
3.4.1 Biomarkers and Diagnostic Tests for Breast Cancer
3.4.2 Biomarkers and Diagnostic Tests for Prostate Cancer
3.4.3 Biomarkers and Diagnostic Tests for Colorectal Cancer
3.5 Companion Diagnostics and Collaborations between Two Industries
3.6 LDTs to be Replaced by Approved Tests
3.7 Decentralisation of Diagnostic Tests
3.8 Next-Generation Cancer Diagnostics: Drivers and Restraints 2015-2025
4. Next-Generation Cancer Diagnostics Submarkets 2015-2025
4.1 Advanced PCR Techniques
4.1.1 Advanced PCR Techniques Market Forecast 2015-2025
4.1.2 Leading Products in the Real-Time PCR Market
4.1.2.1 cobas 4800 System & Oncology Tests (Roche)
4.1.2.2 QuantStudio Dx & 7500 Fast Dx (Thermo Fisher)
4.1.2.3 Rotor-Gene Q & therascreen Tests (Qiagen)
4.1.2.4 Oncotype DX (Genomic Health)
4.1.3 Leading Products in the Digital PCR Market
4.1.4 Pap Tests Being Replaced by PCR Assays
4.1.5 Advanced PCR-Based Techniques: Drivers and Restraints 2015-2025
4.2 In Situ Hybridisation (ISH)
4.2.1 ISH Cancer Diagnostics Market Forecast 2015-2025
4.2.2 Leading Products in the ISH Cancer Diagnostics Market
4.2.3 HER2 Tests for Breast Cancer
4.2.4 ISH Cancer Diagnostics: Drivers and Restraints 2015-2025
4.3 Circulating Tumour Cells (CTCs) Analysis
4.3.1 CTCs Analysis Market Forecast 2015-2025
4.3.2 Leading Product in the CTCs Analysis Market
4.3.2.1 CellSearch System (Janssen Diagnostics)
4.3.3 Epic Sciences and LabCorp to Expand in Asia Markets
4.3.4 CTCs Separation by Ultrasound
4.3.5 CTC Clusters More Likely to Cause Metastasis?
4.3.6 CTCs Analysis: Drivers and Restraints 2015-2025
4.4 Microarray
4.4.1 Microarray Cancer Diagnostics Market Forecast 2015-2025
4.4.2 Leading Products in the Microarray Market
4.4.2.1 OncoScan FFPE Assay Kit (Affymetrix)
4.4.2.2 MammaPrint (Agendia)
4.4.3 Microarray Cancer Diagnostics: Trends and Developments
4.4.3.1 Array Comparative Genomic Hybridisation (Array CGH)
4.4.4 Microarray Cancer Diagnostics: Drivers and Restraints 2015-2025
4.5 Next-Generation Sequencing (NGS)
4.5.1 NGS Cancer Diagnostics Market Forecast 2015-2025
4.5.2 Leading Products in the NGS Market
4.5.2.1 MiSeqDx (Illumina)
4.5.2.2 Ion PGM Dx System (Thermo Fisher)
4.5.2.3 GeneRead DNAseq Targeted Panels V2 (Qiagen)
4.5.3 NGS Cancer Diagnostics: Trends and Developments
4.5.3.1 Myriad Shifting from PCR to NGS Panel
4.5.3.2 Competition in the NGS Market
4.5.3.3 Bio-Rad to Commercialise NGS system for Clinical Use
4.5.3.4 Qiagen Launched NGS Bioinformatics Platform
4.5.4 NGS Cancer Diagnostics: Drivers and Restraints 2015-2025
5. Leading National Markets 2015-2025
5.1 World Next-Generation Cancer Diagnostics Market: Regional Forecast 2015-2025
5.1.1 How Will Regional Market Shares Change to 2025?
5.2 US Next-Generation Cancer Diagnostics Market Forecast 2015-2025
5.2.1 FDA Provides Guidance for Molecular Diagnostic Instruments with Combined Functions
5.2.2 Obama Launched ‘Precision Medicine Initiative’
5.2.3 FDA and CMS to Regulate LDTs
5.3 EU5 Next-Generation Cancer Diagnostics Market Forecast 2015-2025
5.3.1 Germany: Leading Market in the EU
5.3.2 France: Reduction in Healthcare Spending
5.3.3 UK: 100,000 Genomes Project
5.3.4 Spain: Recovering from Financial Crisis
5.3.5 Italy: Decreasing Reimbursement
5.4 Japanese Next-Generation Cancer Diagnostics Market Forecast 2015-2025
5.4.1 Takeda Collaborated with NCC in Genomic Screening Project
5.4.2 Qiagen Partnered Hitachi on PCR and NGS Technologies
5.4.3 Increase Cancer Rates in Fukushima after Nuclear Disaster?
5.5 Chinese Next-Generation Cancer Diagnostics Market Forecast 2015-2025
5.5.1 Illumina Entering the Chinese Market
5.5.2 Epigenomics Colorectal Cancer Test Approved in China
5.5.3 China Offered Free Screenings for Cervical and Breast Cancer
5.6 Indian Next-Generation Cancer Diagnostics Market Forecast 2015-2025
5.6.1 Lack of Genetic Testing Regulation
5.6.2 Cancer Genetics Launched NGS Cancer Panel in India
5.7 Brazilian Next-Generation Cancer Diagnostics Market Forecast 2015-2025
5.8 Russian Next-Generation Cancer Diagnostics Market Forecast 2015-2025
5.8.1 IBM’s Collaboration with Russian Companies to Advance Clinical Decision Making
6. Leading Companies in the Next-Generation Cancer Diagnostics Market 2015
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics: Product Portfolio, 2015
6.1.2 Roche Diagnostics: Diagnostics Outlook
6.1.3 Cobas HPV Test Approved in the US in 2014
6.1.4 Roche Diagnostics: Recent M&A Activity
6.1.5 Roche Coming Back to the NGS Business?
6.2 Abbott Laboratories
6.2.1 Abbott: Next-Generation Cancer Diagnostics Product Portfolio 2015
6.2.2 Abbott: Diagnostics Outlook
6.2.3 Abbott Obtained Exclusive License for Bladder Cancer Biomarker FGFR3
6.3 Qiagen
6.3.1 Qiagen: Next-Generation Cancer Diagnostics Product Portfolio 2015
6.3.1.1 Molecular Diagnostics Kits
6.3.1.2 Real-Time PCR: Rotor-Gene Q
6.3.1.3 Bioinformatics for NGS
6.3.2 Qiagen: Market Outlook
6.3.3 HalioDx Created from Qiagen Marseille
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific: Business Segments
6.4.2 Thermo Fisher: Next-Generation Cancer Diagnostics Product Portfolio 2015
6.4.2.1 QuantStudio 3D (Digital PCR)
6.4.2.2 In Situ Hybridisation
6.4.2.3 Microarray Slides
6.4.2.4 Next-Generation Sequencing
6.4.2.5 Real-Time PCR for Oncology in Pipeline?
6.4.3 Thermo Fisher: Life Sciences Outlook
6.4.4 NGS Oncomine Focus Assay for Oncology Research
6.5 Agilent Technologies
6.5.1 Agilent: Next-Generation Cancer Diagnostics Product Portfolio 2015
6.5.1.1 NGS Enrichment Platforms
6.5.1.2 Cytogenetic Research and Microarrays
6.5.1.3 Other Products
6.5.2 Agilent: Life Sciences and Diagnostics Outlook
6.5.3 Partnerships and Collaborations for Companion Diagnostics
6.6 Hologic
6.6.1 Hologic: Next-Generation Cancer Diagnostics Product Portfolio 2015
6.6.1.1 Aptima HPV Assay and Cervista HPV Assay
6.6.1.2 Progensa PCA3 Assay
6.6.2 Hologic: Diagnostics Sales Outlook
6.7 Illumina
6.7.1 Illumina: Technology and Product Portfolio 2015
6.7.1.1 Sequencing Technology
6.7.1.2 BeadArray Microarray
6.7.1.3 Consumables
6.7.1.4 Services
6.7.2 Illumina: Sales Outlook
6.7.3 Illumina: Recent M&A Activity
6.7.4 Joined Forces with UK Government for 100,000 Genomes Project
6.7.5 Partnered with Merck Serono to Develop NGS Cancer Diagnostics
6.7.6 Investing on Synthetic DNA Manufacturing Technology
6.8 Myriad Genetics
6.8.1 Myriad: Next-Generation Cancer Diagnostics Product Portfolio 2015
6.8.2 Myriad: Sales Outlook
6.8.3 New Landscape in the BRCA Diagnostic Market
7. Qualitative Analysis of the Next-Generation Cancer Diagnostics Market 2015-2025
7.1 SWOT Analysis of the Next-Generation Cancer Diagnostics Market
7.2 Strengths
7.2.1 Global Cancer Rates Set to Soar
7.2.2 Increasing Awareness of Molecular Cancer Diagnostics
7.2.3 The Trend in Precision Medicine
7.3 Weaknesses
7.3.1 Industry Facing Increasing Reimbursement Pressure
7.3.2 Physicians’ Reliance on Traditional Methods
7.4 Opportunities
7.4.1 Expanding Biomarkers and Cancer Test Menus
7.4.2 Emerging Market to Provide Future Growth
7.4.3 Companion Diagnostics on the Rise
7.5 Threats
7.5.1 Decreasing Healthcare Spending
7.5.2 Gene Patenting Banned in the US?
8. Research Interviews
8.1 Keith Cannon, Executive Vice President, Aviva Biosciences
8.1.1 Aviva: From Research Laboratories to Clinical and Diagnostic Markets
8.1.2 Ability to Distinguish CTCs is the Key
8.1.3 RedSift(TM): Automated Enrichment of Nucleated Cells
8.1.4 On Drivers and Restraints in the CTC Technologies Market
8.1.5 On the Growth in Regional Markets
8.2 Nobuyoshi Katagiri, Ph.D., Director, Diagnostics Development Department, Oncolys BioPharma
8.2.1 On Future Growth of Oncolys BioPharma
8.2.2 CTCs is Changing the Market
8.2.3 On Current Restraints in the Market
8.2.4 ctDNA May Compete with Oncolys BioPharma’s TelomeScan
9. Conclusions
9.1 The World Next-Generation Cancer Diagnostics Market
9.1.1 Current Leading Next-Generation Cancer Diagnostics Segments
9.1.2 Notable Next-Generation Cancer Diagnostics Companies
9.1.3 Leading Regional Markets
9.1.4 World Next-Generation Cancer Diagnostics Market Forecast 2015-2025
9.2 The Future of the Next-Generation Cancer Diagnostics Market
10. Glossary
【レポート販売概要】
■ タイトル：次世代がん診断技術の世界市場：先進PCR技術、CTC検査、FISH検査、マイクロアレイ、次世代シークエンシング技術■ 英文：Next-Generation Cancer Diagnostics Market Forecast 2015-2025 : Opportunities for Leading Companies Developing Advanced PCR Techniques, CTC tests, FISH tests, Microarrays and NGS Technologies
■ 発行日：2015年7月
■ 調査会社：visiongain
■ 商品コード：VGAIN5081913
■ 調査対象地域：グローバル
- 血液凝固/止血分析装置の世界市場予測（～2021）： 臨床検査室、PoCT分析装置The coagulation analyzer market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The market consists of various products that are used by clinical laboratories, hospitals, patient self-testing and others. The high incidence and large economic burden of blood related diseases and CVD’s, rise in healthcare spending has resulted in th …
- 繊維機械のグローバル市場（2014-2018）About Textile Machinery Textile machinery is used to produce yarns, fabrics, and threads and in the finishing processes of the Textile industry. There are four major types of textile machinery, namely, spinning, weaving, texturing, and knitting machinery. TechNavio's analysts forecast the Global Textile Machinery market will grow at a CAGR of 14.02 percent over the period 2013-2018. Covered in thi …
- 世界の空港手荷物搬送設備市場（2013 – 2020）This report presents a complete market study of the global commercial airport baggage handling system (BHS) market from 2013 to 2020. It also provides the factors that drive the market, the challenges the market face, and the restraints that impact the growth of the baggage handling process market and its industry. The factors that affect the baggage handling system market are terminal expansions, …
- デジタルツインの世界市場2019-2023Global Digital Twin Market: About this market Technavio’s digital twin market analysis considers sales from both on-premise and cloud deployment. Our analysis also considers the sales of the digital twin in APAC, Europe, North America, South America, and MEA. In 2018, the on-premise segment had a significant market share, and this trend is expected to continue over the forecast period. Factors suc …
- シンフィルム(Thin-Film)印刷電池市場2014-2021NanoMarkets has provided coverage on the thin-film and printed batteries market for six years and has a deep understanding of what makes this market tick. During the period we have covered these power sources, some of the firms in this space have made slow but steady progress both technically and in terms of business development; a few of them are generating significant revenue. Other thin-film an …
- 工業用潤滑剤の世界市場2016-2020：鉱油系潤滑剤、合成油系潤滑剤、バイオベース潤滑剤About Industrial Lubricants Lubricants play a vital role in sectors such as automotive, manufacturing, aviation, and marine. They are used in both new and old machines and equipment to reduce friction, which increases with time because of wear and tear of surfaces. Manufacturers are focusing on methods to improve efficiency and effectiveness of lubricants as it will reduce the maintenance cost of …
- 小型トラック用ステアリングシステムの世界市場2019-2023About this market The growth of the global light-duty truck steering system market is highly dependent on the sales of light-duty trucks. China, Japan, and countries in North America and Western Europe, which comprise the major markets for light-duty trucks, are expected to see a slowdown in growth or even lower sales during the forecast period. Increasing manufacturing activities in India will ra …
- 世界の戦闘医療・戦場医療市場における主要な革新企業分析The latest report from business intelligence provider visiongain offers comprehensive analysis of the leading companies in combat medicine and battlefield healthcare. Visiongain assesses that this market will undergo strong growth in a variety of key areas. Now: Repetitive blast exposure has been tied to brain changes in combat vets. How can combat medical equipment affect this? This is an example …
- Royale Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Royale Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Royale Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- グルテンフリー食品の世界市場：グルテンフリーベーカリー、ピザ、パスタ、シリアル、菓子The gluten-free products market has been segmented on the basis of type, source, and region. The market for gluten-free products is projected to grow at a CAGR of 10.4% from 4.63 Billion in 2015 to reach USD 7.59 Billion in 2020. The gluten-free products market is segmented on the basis of type into bakery products, pizzas & pastas, cereals & snacks, savories, and others. In 2014, the global glute …
- アラキドン酸（ARA）の世界市場：形状別（固体、溶媒）、用途別（乳児用調製粉乳、サプリメント）、地域別、競合別、セグメント予測The global arachidonic acid market size is expected to reach USD 281.0 million by 2025 expanding at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Increasing product usage in baby food and health supplements is anticipated to drive the market growth. The infant formula segment is expected to witness a significant growth on account of increasing product usage in baby nutriti …
- 人工採油の世界市場予測：水中電動ポンプ、ロッドリフト、プログレッシブキャビティポンプ、ガスリフトThe global artificial lift market is projected to grow at a CAGR of 4.91% from 2016 to 2021, to reach a market size of USD 9.69 Billion by 2021. This growth is attributed to increasing oil & gas production from unconventional resources such as shale gas, heavy oil, and tight oil. The report segments the artificial lift market on the basis of mechanism into pump assisted and gas assisted. The pump …
- 世界の無機塩基市場2015The Global Inorganic Bases Industry Report 2015 is a professional and in-depth study on the current state of the Inorganic Bases industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Inorganic Bases market analysis is provided for the international markets including development trends, competitive landsc …
- Sasol Limited：石油・ガスの開発・生産動向及びコスト分析– 2012Sasol Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Sasol Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational …
- Uterine Fibroids：グローバル臨床試験レビューH2, 2013Uterine Fibroids Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Uterine Fibroids Global Clinical Trials Review, H2, 2013" provides data on the Uterine Fibroids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment statu …
